News & Analysis

Latest content

Nestlé, Coca-Cola most valuable brands as food and beverage industry bounces back from covid

Food brand values have returned to pre-pandemic levels, according to a new report

18 August 2022

The five challenges that will define the Campinos legacy at the EPO

The Portuguese president of the agency was recently appointed to a second term and now has until the end of June 2028 to leave an indelible mark on Europe’s patent story

18 August 2022

How to obtain commercially useful patents for AI in Europe

Although it is tempting to think that such rights are too difficult to secure, there are ways through to getting meaningful protection from the EPO

18 August 2022

Patent plaintiffs flee Waco after random WDTX case assignment order

The US District Court for the District of Delaware has seen a patent case surge as Judge Alan Albright’s docket shrinks

17 August 2022

Mysterious patent-purchasing biotech now embroiled in trade secrets dispute

New market entrant Terran Biosciences takes action against rival Compass Pathways in Maryland district court

17 August 2022

How Pure Storage generates – and demonstrates - ROI with its patents

The company may have a small IP team but it has consistently proved its worth over a number of years

17 August 2022

The sword, the shield, the olive branch – NuCurrent’s path to IP value creation

In an exclusive interview, the company’s CEO Jacob Babcock details its journey to becoming a technology licensing business

16 August 2022

A new wave of US biosimilar patent disputes begins

After a lull in biologic versus imitator disputes, Regeneron has sued Mylan and more litigation is likely to follow

16 August 2022

The patent challenges of the Indian company set to become the world’s biggest biosimilars business

In an exclusive interview Biocon Biologics’ chief IP counsel explains the issues that he and his team focus on – and how an upcoming, big-ticket merger will lead to change

16 August 2022

IPValue – the licensing business that rarely goes to court

Despite holding thousands of patents and being active for over 20 years, Docket Navigator data shows that the firm’s entities have filed just 32 litigation actions since 2008

15 August 2022

Get unlimited access to all IAM content